Annual Meeting Highlights

2017 ESMO Meeting Highlights in Pancreatic Cancer
2017 ESMO Meeting Highlights in Pancreatic Cancer
CME, CPE
Andrea J. Bullock, MD, MPH; J. Randolph Hecht, MD; Philip A. Philip, MD, PhD, FRCP
Release Date: October 31, 2017
Expiration Date: October 31, 2018
Pancreatic cancer has now moved from the fourth leading cause of cancer-related death in the United States to the third, surpassing breast cancer. It is one of the few cancers where mortality is increasing, and most recent statistics show the 5-year overall survival rate for patients diagnosed with pancreatic cancer is just 8%. Although these statistics are illustrative of a poor prognosis, recent advances in pancreatic cancer treatment options hold promise in improving outcomes for patients.

In this activity, participants will hear from leading experts in pancreatic cancer as they provide a review of key abstracts presented this year at the European Society of Medical Oncology (ESMO) conference held in Madrid Spain.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation
Begin, Earn CreditView Only, No Credit
 
2017 ASCO Meeting Highlights in Pancreatic Cancer
2017 ASCO Meeting Highlights in Pancreatic Cancer
CME, CPE, CNE
Tanios Bekaii-Saab, MD, FACP; Alok A. Khorana, MD; Philip A. Philip, MD, PhD, FRCP, FABC; Ramesh Ramanathan, MD; Andrea Wang-Gillam, MD, PhD
Release Date: June 30, 2017
Expiration Date: June 30, 2018
This activity will describe eight clinically meaningful studies in pancreatic cancer that were presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois. Participants will have the opportunity to review summaries of the clinical data, including commentary from investigators, regarding the significance of the data and its impact on practice. The presentations will provide an overview of investigational agents as well as combination therapies, in both the first-line and second-line, in the advanced/metastatic setting.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation
Begin, Earn CreditView Only, No Credit
 
2016 ASCO Meeting Highlights in Pancreatic Cancer
2016 ASCO Meeting Highlights in Pancreatic Cancer
CME, CPE
Kate O'Rourke
Release Date: June 30, 2016
Expiration Date: June 30, 2017
This activity will describe five exciting and clinically meaningful studies in pancreatic cancer that were presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois. Participants will have the opportunity to review summaries of the clinical data, including commentary from investigators and authors, regarding the significance of the data and its impact on practice. The presentations address immuno-oncology, new agents, and novel combination therapies in both the first-line and advanced/metastatic setting for patients with pancreatic cancer.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Incyte Corporation
View Only, CE ExpiredView Only, No Credit
 

Partners in Pancreatic Cancer would like to recognize and thank Celgene Corporation
for their educational support of PartnersinPancreaticCancer.com.

©2018 MediCom Worldwide, Inc. All rights reserved